Cargando…

Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder

OBJECTIVE: This investigation aims to determine the antidepressant role of Xingpijieyu formula (XPJYF) mediated via gut microbiota (GM)–brain axis. METHODS: We collected fecal microbiota from patients with depressive disorder (DD) and cultured microbiota in vitro. Some of microbiota were transplante...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yannan, Yang, Lixuan, Li, Junnan, Gao, Wei, Zhao, Zhonghui, Dong, Kaiqiang, Duan, Wenzhe, Dai, Baoan, Guo, Rongjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873506/
https://www.ncbi.nlm.nih.gov/pubmed/36550591
http://dx.doi.org/10.1111/cns.14049
_version_ 1784877611029102592
author Li, Yannan
Yang, Lixuan
Li, Junnan
Gao, Wei
Zhao, Zhonghui
Dong, Kaiqiang
Duan, Wenzhe
Dai, Baoan
Guo, Rongjuan
author_facet Li, Yannan
Yang, Lixuan
Li, Junnan
Gao, Wei
Zhao, Zhonghui
Dong, Kaiqiang
Duan, Wenzhe
Dai, Baoan
Guo, Rongjuan
author_sort Li, Yannan
collection PubMed
description OBJECTIVE: This investigation aims to determine the antidepressant role of Xingpijieyu formula (XPJYF) mediated via gut microbiota (GM)–brain axis. METHODS: We collected fecal microbiota from patients with depressive disorder (DD) and cultured microbiota in vitro. Some of microbiota were transplanted into germ‐free rats with the intragastric administration of XPJYF grain at the dose of 1.533 g/kg/day. The behaviors were studied by forced swimming test, open field test, sucrose preference test, and body weight. Products of hypothalamus–pituitary–adrenocortical (HPA) axis, neurotransmitter, and serum cytokines were investigated by enzyme linked immunosorbent assay. Glial fibrillary acidic protein (GFAP), a biomarker of astrocyte, was quantified using immunofluorescence. Microbiota culturing in vitro after XPJYF treatment was analyze by 16 s RNA sequencing technology. We used lipopolysaccharide (LPS) to mimic activated rat primary astrocyte in vitro. Brain‐derived neurotrophic factor (BDNF), cytokines, and oxidative stress factors were determined by western blotting, and glycometabolism in astrocyte was investigated by 2‐deoxy‐D‐glucose (2‐DG) uptake, adenosine triphosphate (ATP), and glucose‐1‐phosphate (G1P) kits. RESULTS: Microbiota composition during 8 mg/ml of XPJYF (H12‐8) for 12 h showed the more consistency. Lactococcus is enriched in DD‐derived microbiota composition, and Biffdobacterium and Lactobacillus in H12‐8 group. GLUCOSE1PMETAB‐PWY and PWY‐7328 of which biofunctions were dominantly encoded by Biffdobacterium were the top two of altered pathways. XPJYF improved behaviors and repressed astrocyte activation in depression rats. XPJYF elevated 2‐DG uptake, ATP, glucose‐1‐phosphate, and brain‐derived neurotrophic factor (BDNF), and inhibited cytokines and oxidative stress in LPS‐induced astrocyte. CONCLUSION: XPJYF treatment targets inflammation, activation, and glycometabolim in astrocyte via gut microbiota modulation, thereby improve animal behaviors, HPA axis dysfunction, and neurotransmitter synthesis in depression rats.
format Online
Article
Text
id pubmed-9873506
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98735062023-01-27 Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder Li, Yannan Yang, Lixuan Li, Junnan Gao, Wei Zhao, Zhonghui Dong, Kaiqiang Duan, Wenzhe Dai, Baoan Guo, Rongjuan CNS Neurosci Ther Original Articles OBJECTIVE: This investigation aims to determine the antidepressant role of Xingpijieyu formula (XPJYF) mediated via gut microbiota (GM)–brain axis. METHODS: We collected fecal microbiota from patients with depressive disorder (DD) and cultured microbiota in vitro. Some of microbiota were transplanted into germ‐free rats with the intragastric administration of XPJYF grain at the dose of 1.533 g/kg/day. The behaviors were studied by forced swimming test, open field test, sucrose preference test, and body weight. Products of hypothalamus–pituitary–adrenocortical (HPA) axis, neurotransmitter, and serum cytokines were investigated by enzyme linked immunosorbent assay. Glial fibrillary acidic protein (GFAP), a biomarker of astrocyte, was quantified using immunofluorescence. Microbiota culturing in vitro after XPJYF treatment was analyze by 16 s RNA sequencing technology. We used lipopolysaccharide (LPS) to mimic activated rat primary astrocyte in vitro. Brain‐derived neurotrophic factor (BDNF), cytokines, and oxidative stress factors were determined by western blotting, and glycometabolism in astrocyte was investigated by 2‐deoxy‐D‐glucose (2‐DG) uptake, adenosine triphosphate (ATP), and glucose‐1‐phosphate (G1P) kits. RESULTS: Microbiota composition during 8 mg/ml of XPJYF (H12‐8) for 12 h showed the more consistency. Lactococcus is enriched in DD‐derived microbiota composition, and Biffdobacterium and Lactobacillus in H12‐8 group. GLUCOSE1PMETAB‐PWY and PWY‐7328 of which biofunctions were dominantly encoded by Biffdobacterium were the top two of altered pathways. XPJYF improved behaviors and repressed astrocyte activation in depression rats. XPJYF elevated 2‐DG uptake, ATP, glucose‐1‐phosphate, and brain‐derived neurotrophic factor (BDNF), and inhibited cytokines and oxidative stress in LPS‐induced astrocyte. CONCLUSION: XPJYF treatment targets inflammation, activation, and glycometabolim in astrocyte via gut microbiota modulation, thereby improve animal behaviors, HPA axis dysfunction, and neurotransmitter synthesis in depression rats. John Wiley and Sons Inc. 2022-12-22 /pmc/articles/PMC9873506/ /pubmed/36550591 http://dx.doi.org/10.1111/cns.14049 Text en © 2022 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Li, Yannan
Yang, Lixuan
Li, Junnan
Gao, Wei
Zhao, Zhonghui
Dong, Kaiqiang
Duan, Wenzhe
Dai, Baoan
Guo, Rongjuan
Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder
title Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder
title_full Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder
title_fullStr Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder
title_full_unstemmed Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder
title_short Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder
title_sort antidepression of xingpijieyu formula targets gut microbiota derived from depressive disorder
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873506/
https://www.ncbi.nlm.nih.gov/pubmed/36550591
http://dx.doi.org/10.1111/cns.14049
work_keys_str_mv AT liyannan antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT yanglixuan antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT lijunnan antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT gaowei antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT zhaozhonghui antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT dongkaiqiang antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT duanwenzhe antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT daibaoan antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder
AT guorongjuan antidepressionofxingpijieyuformulatargetsgutmicrobiotaderivedfromdepressivedisorder